Sign inGet started

Dulac Edward J III

Insider CIK 1821530 · FATE Chief Financial Officer · NTLA EVP, Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NTLA Intellia Therapeutics, Inc S Sale2026-07-222026-07-248,111$11.25 $91.2K148,175SEC↗
NTLA Intellia Therapeutics, Inc S Sale2026-07-022026-07-064,677$18.00 $84.2K156,286SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2026-03-012026-03-0387,543— $087,543SEC↗
NTLA Intellia Therapeutics, Inc A Award2026-03-012026-03-0361,280— $0160,963SEC↗
NTLA Intellia Therapeutics, Inc S Sale2026-01-052026-01-076,379$9.21 $58.8K99,683SEC↗
NTLA Intellia Therapeutics, Inc S Sale2025-07-232025-07-257,462$14.02 $104.6K106,062SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2025-03-012025-03-0467,429— $067,429SEC↗
NTLA Intellia Therapeutics, Inc A Award2025-03-012025-03-0447,200— $0113,524SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2024-07-222024-07-2496,219— $096,219SEC↗
NTLA Intellia Therapeutics, Inc A Award2024-07-222024-07-2466,324— $066,324SEC↗
FATE FATE THERAPEUTICS INC S Sale2024-03-042024-03-052,447$7.77 $19.0K101,479SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2024-02-012024-02-02425,000— $0425,000SEC↗
FATE FATE THERAPEUTICS INC S Sale2024-01-292024-01-301,849$5.00 $9.2K103,926SEC↗
FATE FATE THERAPEUTICS INC S Sale2024-01-092024-01-107,028$4.37 $30.7K105,775SEC↗
FATE FATE THERAPEUTICS INC S Sale2024-01-022024-01-035,182$3.66 $19.0K112,803SEC↗
FATE FATE THERAPEUTICS INC S Sale2023-12-182023-12-191,585$3.50 $5.5K117,985SEC↗
FATE FATE THERAPEUTICS INC S Sale2023-08-182023-08-214,718$2.80 $13.2K119,570SEC↗
FATE FATE THERAPEUTICS INC S Sale2023-07-052023-07-065,182$4.83 $25.0K124,288SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2023-02-062023-02-07425,000— $0425,000SEC↗
FATE FATE THERAPEUTICS INC S Sale2023-01-102023-01-117,331$5.24 $38.4K129,470SEC↗
FATE FATE THERAPEUTICS INC S Sale2022-08-182022-08-194,703$29.75 $139.9K137,233SEC↗
FATE FATE THERAPEUTICS INC S Sale2022-08-182022-08-19432$30.41 $13.1K136,801SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2022-01-252022-01-2753,058— $053,058SEC↗
FATE FATE THERAPEUTICS INC A Award2022-01-252022-01-2733,302— $0141,936SEC↗
FATE FATE THERAPEUTICS INC S Sale2022-01-112022-01-13390$49.16 $19.2K108,634SEC↗
FATE FATE THERAPEUTICS INC S Sale2022-01-112022-01-131,380$48.25 $66.6K109,024SEC↗
FATE FATE THERAPEUTICS INC M Exercise deriv2021-12-202021-12-2114,437— $0128,238SEC↗
FATE FATE THERAPEUTICS INC S Sale2021-12-202021-12-2115,977$60.00 $958.6K110,404SEC↗
FATE FATE THERAPEUTICS INC M Exercise2021-12-202021-12-2114,437$35.52 $512.8K126,381SEC↗
FATE FATE THERAPEUTICS INC A Award2021-11-192021-11-2259,540— $0111,944SEC↗
FATE FATE THERAPEUTICS INC M Exercise deriv2021-09-282021-09-3017,325— $0142,675SEC↗
FATE FATE THERAPEUTICS INC S Sale2021-09-282021-09-3019,460$62.53 $1.22M52,404SEC↗
FATE FATE THERAPEUTICS INC M Exercise2021-09-282021-09-3017,325$35.52 $615.4K71,864SEC↗
FATE FATE THERAPEUTICS INC S Sale2021-08-192021-08-2063$90.00 $5.7K54,539SEC↗
FATE FATE THERAPEUTICS INC S Sale2021-08-192021-08-201,474$88.65 $130.7K54,602SEC↗
FATE FATE THERAPEUTICS INC S Sale2021-08-192021-08-201,937$87.90 $170.3K56,076SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2021-01-202021-01-226,851— $06,851SEC↗
FATE FATE THERAPEUTICS INC A Award2021-01-202021-01-2218,013— $058,013SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2020-08-172020-08-19160,000— $0160,000SEC↗
FATE FATE THERAPEUTICS INC A Award2020-08-172020-08-1940,000— $040,000SEC↗